Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 May;80(5-6):685–692. doi: 10.1038/sj.bjc.6690410

Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell lines

K E Wilson 1, J M S Bartlett 2, E P Miller 1, J F Smyth 1, P Mullen 1, W R Miller 1, S P Langdon 1
PMCID: PMC2362285  PMID: 10360644

Abstract

The extracellular matrix glycoprotein tenascin-C (TN) is overexpressed in the stroma of malignant ovarian tumours particularly at the interface between epithelia and stroma leading to suggestions that it may be involved in the process of invasion (Wilson et al (1996) Br J Cancer 74: 999–1004). To define regulation of TN further and investigate its function in ovarian cancer, a range of cell line models were studied. Concentrations of secreted TN in media from cultures of ovarian fibroblast cell lines were at least 100-fold greater than from carcinoma cell lines. Evidence for paracrine regulation of TN secretion was obtained by co-culture of carcinoma cells with fibroblast cells wherein secretion into the media was greater than from fibroblasts alone. Transforming growth factor (TGF)-β1, insulin-like growth factor (IGF)-II and progesterone all stimulated TN secretion while human choriogonadotropin (hCG), follicle-stimulating hormone (FSH) and γ-interferon inhibited secretion. TGF-β1 produced the greatest stimulation of TN in cultured fibroblasts and its co-expression with TN was examined in primary ovarian tumours. There was a significant association between the presence of moderate–strong expression of TN and TGF-β1. Evidence for TN having a functional role in ovarian carcinoma was obtained from adhesion and migration assays. The PE01, PE04, SKOV-3 and 59M cell lines all demonstrated marked adhesion to plastic coated with TN relative to the control protein bovine serum albumin (BSA) and expressed α2β1 and α3β1 integrins. The SKOV-3 cell line migrated more rapidly through TN than through BSA indicating that TN can facilitate migration of ovarian carcinoma cells. © 1999 Cancer Research Campaign

Keywords: tenascin, ovarian cancer, TGF-β

Full Text

The Full Text of this article is available as a PDF (353.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartlett J. M., Langdon S. P., Scott W. N., Love S. B., Miller E. P., Katsaros D., Smyth J. F., Miller W. R. Transforming growth factor-beta isoform expression in human ovarian tumours. Eur J Cancer. 1997 Dec;33(14):2397–2403. doi: 10.1016/s0959-8049(97)00304-3. [DOI] [PubMed] [Google Scholar]
  2. Chiquet-Ehrismann R., Kalla P., Pearson C. A., Beck K., Chiquet M. Tenascin interferes with fibronectin action. Cell. 1988 May 6;53(3):383–390. doi: 10.1016/0092-8674(88)90158-4. [DOI] [PubMed] [Google Scholar]
  3. Chiquet-Ehrismann R., Kalla P., Pearson C. A. Participation of tenascin and transforming growth factor-beta in reciprocal epithelial-mesenchymal interactions of MCF7 cells and fibroblasts. Cancer Res. 1989 Aug 1;49(15):4322–4325. [PubMed] [Google Scholar]
  4. Chiquet-Ehrismann R. Tenascin and other adhesion-modulating proteins in cancer. Semin Cancer Biol. 1993 Oct;4(5):301–310. [PubMed] [Google Scholar]
  5. Chung C. Y., Erickson H. P. Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C. J Cell Biol. 1994 Jul;126(2):539–548. doi: 10.1083/jcb.126.2.539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Deryugina E. I., Bourdon M. A. Tenascin mediates human glioma cell migration and modulates cell migration on fibronectin. J Cell Sci. 1996 Mar;109(Pt 3):643–652. doi: 10.1242/jcs.109.3.643. [DOI] [PubMed] [Google Scholar]
  7. Erickson H. P., Bourdon M. A. Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. Annu Rev Cell Biol. 1989;5:71–92. doi: 10.1146/annurev.cb.05.110189.000443. [DOI] [PubMed] [Google Scholar]
  8. Giese A., Loo M. A., Norman S. A., Treasurywala S., Berens M. E. Contrasting migratory response of astrocytoma cells to tenascin mediated by different integrins. J Cell Sci. 1996 Aug;109(Pt 8):2161–2168. doi: 10.1242/jcs.109.8.2161. [DOI] [PubMed] [Google Scholar]
  9. Hoffman S., Dutton S. L., Ernst H., Boackle M. K., Everman D., Tourkin A., Loike J. D. Functional characterization of antiadhesion molecules. Perspect Dev Neurobiol. 1994;2(1):101–110. doi: 10.1080/0907676x.1994.9961227. [DOI] [PubMed] [Google Scholar]
  10. Langdon S. P., Lawrie S. S., Hay F. G., Hawkes M. M., McDonald A., Hayward I. P., Schol D. J., Hilgers J., Leonard R. C., Smyth J. F. Characterization and properties of nine human ovarian adenocarcinoma cell lines. Cancer Res. 1988 Nov 1;48(21):6166–6172. [PubMed] [Google Scholar]
  11. Mackie E. J., Chiquet-Ehrismann R., Pearson C. A., Inaguma Y., Taya K., Kawarada Y., Sakakura T. Tenascin is a stromal marker for epithelial malignancy in the mammary gland. Proc Natl Acad Sci U S A. 1987 Jul;84(13):4621–4625. doi: 10.1073/pnas.84.13.4621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mould A. P., Askari J. A., Craig S. E., Garratt A. N., Clements J., Humphries M. J. Integrin alpha 4 beta 1-mediated melanoma cell adhesion and migration on vascular cell adhesion molecule-1 (VCAM-1) and the alternatively spliced IIICS region of fibronectin. J Biol Chem. 1994 Nov 4;269(44):27224–27230. [PubMed] [Google Scholar]
  13. Pearson C. A., Pearson D., Shibahara S., Hofsteenge J., Chiquet-Ehrismann R. Tenascin: cDNA cloning and induction by TGF-beta. EMBO J. 1988 Oct;7(10):2977–2982. doi: 10.1002/j.1460-2075.1988.tb03160.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Rettig W. J., Erickson H. P., Albino A. P., Garin-Chesa P. Induction of human tenascin (neuronectin) by growth factors and cytokines: cell type-specific signals and signalling pathways. J Cell Sci. 1994 Feb;107(Pt 2):487–497. [PubMed] [Google Scholar]
  15. Spring J., Beck K., Chiquet-Ehrismann R. Two contrary functions of tenascin: dissection of the active sites by recombinant tenascin fragments. Cell. 1989 Oct 20;59(2):325–334. doi: 10.1016/0092-8674(89)90294-8. [DOI] [PubMed] [Google Scholar]
  16. Walker R. A., Dearing S. J., Gallacher B. Relationship of transforming growth factor beta 1 to extracellular matrix and stromal infiltrates in invasive breast carcinoma. Br J Cancer. 1994 Jun;69(6):1160–1165. doi: 10.1038/bjc.1994.228. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES